These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20049508)

  • 1. Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab.
    Malik A; Sood S; Narang S
    Int Ophthalmol; 2010 Aug; 30(4):425-8. PubMed ID: 20049508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane.
    Shanmugam MP; Mythri HM; Shetty NS
    Indian J Ophthalmol; 2007; 55(6):490-1. PubMed ID: 17951923
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks.
    Sachdev N; Vishwanathan K; Gupta V; Singh R; Gupta A
    Indian J Ophthalmol; 2007; 55(6):457-8. PubMed ID: 17951904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.
    Lazic R; Gabric N
    Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):68-73. PubMed ID: 17111146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.
    Artunay O; Rasier R; Yuzbasioglu E; Sengül A; Bahcecioglu H
    Int Ophthalmol; 2009 Aug; 29(4):289-91. PubMed ID: 18825317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab.
    Battaglia Parodi M; De Benedetto U; Knutsson KA; Scotti F; Librando A; Bandello F; Iacono P
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):202-4. PubMed ID: 22149640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.
    Ben Yahia S; Herbort CP; Jenzeri S; Hmidi K; Attia S; Messaoud R; Khairallah M
    Int Ophthalmol; 2008 Aug; 28(4):311-6. PubMed ID: 18401552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for myopic choroidal neovascularization.
    Rensch F; Spandau UH; Schlichtenbrede F; von Baltz S; Libondi T; Jonas JB; Vossmerbaeumer U
    Ophthalmic Surg Lasers Imaging; 2008; 39(3):182-5. PubMed ID: 18556936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R; Soliman W; Lund-Andersen H; Larsen M
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up.
    Costagliola C; Semeraro F; Cipollone U; Rinaldi M; della Corte M; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2009 Aug; 247(8):1031-7. PubMed ID: 19404665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy.
    Mandal S; Sinha S; Abbas Z; Venkatesh P
    Indian J Ophthalmol; 2011; 59(4):338-9. PubMed ID: 21666337
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal bevacizumab for uveitic choroidal neovascularization.
    Doctor PP; Bhat P; Sayed R; Foster CS
    Ocul Immunol Inflamm; 2009; 17(2):118-26. PubMed ID: 19412874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
    Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
    Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for the treatment of feeder vessel of subfoveal choroidal neovascularization.
    Theodossiadis PG; Grigoropoulos VG; Emfietzoglou I; Vergados J; Chalkiadakis J; Theodossiadis GP
    Eur J Ophthalmol; 2007; 17(5):853-6. PubMed ID: 17932868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
    Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
    Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).
    Ahmadieh H; Vafi N
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1731-3. PubMed ID: 17653753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization.
    Arias L; Caminal JM; Rubio M; Pujol O; Arruga J
    Eur J Ophthalmol; 2007; 17(6):992-5. PubMed ID: 18050131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta.
    Rishi P; Rishi E; Venkatraman A
    Indian J Ophthalmol; 2012; 60(3):229-31. PubMed ID: 22569391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
    Rush RB; Rush SW; Aragon AV; Ysasaga JE
    Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.